{"id":79686,"date":"2022-08-19T00:29:24","date_gmt":"2022-08-18T22:29:24","guid":{"rendered":"https:\/\/www.csregypt.com\/?p=79686"},"modified":"2022-08-19T00:29:24","modified_gmt":"2022-08-18T22:29:24","slug":"eib-provides-e22-m-to-polands-ryvu-therapeutics-to-develop-new-cancer-treatment","status":"publish","type":"post","link":"https:\/\/csregypt.com\/en\/eib-provides-e22-m-to-polands-ryvu-therapeutics-to-develop-new-cancer-treatment\/","title":{"rendered":"EIB provides \u20ac22\u00a0m to Poland\u2019s Ryvu Therapeutics to develop new cancer treatment"},"content":{"rendered":"

The European Investment Bank (EIB)<\/a> is providing \u20ac22\u00a0million \u00a0in financing\u00a0to Ryvu Therapeutics<\/a>, a Polish\u00a0<\/u>clinical-stage drug discovery and development company, to develop new cancer treatment.<\/p>\n

The EIB\u2019s support will help Ryvu finance its development pipeline of new cancer treatments from discovery through to clinical trials. Ultimately, Ryvu aims to address the clinical limitations of current treatments in oncology and provide patients with access to innovative therapies for haematologic and solid tumors.<\/p>\n

EIB Vice-President\u00a0Teresa Czerwi\u0144ska said \u201cFinancing projects within the field of research, development and innovation is one of the EIB’s top priorities and is especially relevant today, as the world suffers from the health crisis caused by the pandemic. Support for innovative companies like Ryvu specializing in advanced biotech research is clearly needed and we are delighted to assist this ambitious company, which has a notable drug discovery and development track record. The EIB\u2019s investment will strengthen Ryvu Therapeutics\u2019 research, development and innovation capacity and competitiveness for the wider social benefit.\u201d<\/p>\n

Innovation, research, digital economy and the development of human capital are top priorities for the EIB Group. In 2021, the EIB Group\u2019s overall financing for innovation, digital transformation and human capital projects reached \u20ac20.7\u00a0billion worldwide, of which \u20ac1.5\u00a0billion went to Poland (up from \u20ac1.2\u00a0billion in 2020).<\/p>\n

\u201cWe are very pleased to receive funding from the European Investment Bank, which plays such an instrumental role in providing financial support to innovation-driven companies like Ryvu that seek to develop new and potentially life-saving medicines,\u201d said\u00a0Pawel Przewiezlikowski, Chief Executive Officer of Ryvu Therapeutics. \u201cWe would like to thank the EIB for their collaboration, as this funding will help Ryvu continue to advance our clinical-stage oncology pipeline, including RVU120 in clinical development for the treatment of hematologic and solid tumors, as well as earlier stage projects.\u201d<\/p>\n

Valdis Dombrovskis, Executive Vice-President of the European Commission for an Economy that Works for People, said \u201cI welcome this investment by the EIB, backed by the Investment Plan for Europe, in Polish company Ryvu Therapeutics. It is great news for Europe\u2019s competitiveness and its location as a research hub for innovations that change and save people\u2019s lives. The additional funding will go towards the discovery, research and development of innovative therapeutics to treat cancer patients. This investment will also support the regional economy and create highly skilled jobs in the process.\u201d<\/p>\n

Ryvu Therapeutics is already one of the main employers of highly qualified researchers in the biotech field in Poland. With research and development (R&D) activities based in Krak\u00f3w, the additional investment in Ryvu will contribute to the creation of new highly skilled jobs and encourage economic growth in the region.<\/p>\n

\n","protected":false},"excerpt":{"rendered":"

The European Investment Bank (EIB) is providing \u20ac22\u00a0million \u00a0in financing\u00a0to Ryvu Therapeutics, a Polish\u00a0clinical-stage drug discovery and development company, to develop new cancer treatment. The EIB\u2019s support will help Ryvu finance its development pipeline of new cancer treatments from discovery through to clinical trials. Ultimately, Ryvu aims to address the clinical limitations of current treatments […]<\/p>\n","protected":false},"author":410,"featured_media":79687,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6031,984],"tags":[],"yoast_head":"\nEIB provides \u20ac22\u00a0m to Poland\u2019s Ryvu Therapeutics to develop new cancer treatment - Csr Egypt<\/title>\n<meta name=\"description\" content=\"EIB is providing \u20ac22\u00a0million \u00a0in financing\u00a0to Ryvu Therapeutics, a Polish\u00a0clinical-stage drug discovery and development company, to develop new cancer treatment.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/csregypt.com\/en\/eib-provides-e22-m-to-polands-ryvu-therapeutics-to-develop-new-cancer-treatment\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EIB provides \u20ac22\u00a0m to Poland\u2019s Ryvu Therapeutics to develop new cancer treatment - Csr Egypt\" \/>\n<meta property=\"og:description\" content=\"EIB is providing \u20ac22\u00a0million \u00a0in financing\u00a0to Ryvu Therapeutics, a Polish\u00a0clinical-stage drug discovery and development company, to develop new cancer treatment.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/csregypt.com\/en\/eib-provides-e22-m-to-polands-ryvu-therapeutics-to-develop-new-cancer-treatment\/\" \/>\n<meta property=\"og:site_name\" content=\"Csr Egypt\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/csregypt\/\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-18T22:29:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/csregypt.com\/wp-content\/uploads\/2022\/08\/Untitled-17.png\" \/>\n\t<meta property=\"og:image:width\" content=\"600\" \/>\n\t<meta property=\"og:image:height\" content=\"544\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Marwa Zein\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@egyptcsrforum\" \/>\n<meta name=\"twitter:site\" content=\"@egyptcsrforum\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Marwa Zein\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/csregypt.com\/en\/eib-provides-e22-m-to-polands-ryvu-therapeutics-to-develop-new-cancer-treatment\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/csregypt.com\/en\/eib-provides-e22-m-to-polands-ryvu-therapeutics-to-develop-new-cancer-treatment\/\"},\"author\":{\"name\":\"Marwa Zein\",\"@id\":\"https:\/\/csregypt.com\/#\/schema\/person\/5df2c73ec5c5eaada424a85f98cd7bec\"},\"headline\":\"EIB provides \u20ac22\u00a0m to Poland\u2019s Ryvu Therapeutics to develop new cancer treatment\",\"datePublished\":\"2022-08-18T22:29:24+00:00\",\"dateModified\":\"2022-08-18T22:29:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/csregypt.com\/en\/eib-provides-e22-m-to-polands-ryvu-therapeutics-to-develop-new-cancer-treatment\/\"},\"wordCount\":458,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/csregypt.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/csregypt.com\/en\/eib-provides-e22-m-to-polands-ryvu-therapeutics-to-develop-new-cancer-treatment\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/csregypt.com\/wp-content\/uploads\/2022\/08\/Untitled-17.png\",\"articleSection\":[\"health\",\"news\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/csregypt.com\/en\/eib-provides-e22-m-to-polands-ryvu-therapeutics-to-develop-new-cancer-treatment\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/csregypt.com\/en\/eib-provides-e22-m-to-polands-ryvu-therapeutics-to-develop-new-cancer-treatment\/\",\"url\":\"https:\/\/csregypt.com\/en\/eib-provides-e22-m-to-polands-ryvu-therapeutics-to-develop-new-cancer-treatment\/\",\"name\":\"EIB provides \u20ac22\u00a0m to Poland\u2019s Ryvu Therapeutics to develop new cancer treatment - Csr Egypt\",\"isPartOf\":{\"@id\":\"https:\/\/csregypt.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/csregypt.com\/en\/eib-provides-e22-m-to-polands-ryvu-therapeutics-to-develop-new-cancer-treatment\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/csregypt.com\/en\/eib-provides-e22-m-to-polands-ryvu-therapeutics-to-develop-new-cancer-treatment\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/csregypt.com\/wp-content\/uploads\/2022\/08\/Untitled-17.png\",\"datePublished\":\"2022-08-18T22:29:24+00:00\",\"dateModified\":\"2022-08-18T22:29:24+00:00\",\"description\":\"EIB is providing \u20ac22\u00a0million \u00a0in financing\u00a0to Ryvu Therapeutics, a Polish\u00a0clinical-stage drug discovery and development company, to develop new cancer treatment.\",\"breadcrumb\":{\"@id\":\"https:\/\/csregypt.com\/en\/eib-provides-e22-m-to-polands-ryvu-therapeutics-to-develop-new-cancer-treatment\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/csregypt.com\/en\/eib-provides-e22-m-to-polands-ryvu-therapeutics-to-develop-new-cancer-treatment\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/csregypt.com\/en\/eib-provides-e22-m-to-polands-ryvu-therapeutics-to-develop-new-cancer-treatment\/#primaryimage\",\"url\":\"https:\/\/csregypt.com\/wp-content\/uploads\/2022\/08\/Untitled-17.png\",\"contentUrl\":\"https:\/\/csregypt.com\/wp-content\/uploads\/2022\/08\/Untitled-17.png\",\"width\":600,\"height\":544,\"caption\":\"EIB provides \u20ac22\u00a0m to Poland\u2019s Ryvu Therapeutics to develop new cancer treatment\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/csregypt.com\/en\/eib-provides-e22-m-to-polands-ryvu-therapeutics-to-develop-new-cancer-treatment\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/csregypt.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"EIB provides \u20ac22\u00a0m to Poland\u2019s Ryvu Therapeutics to develop new cancer treatment\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/csregypt.com\/#website\",\"url\":\"https:\/\/csregypt.com\/\",\"name\":\"\u0633\u064a \u0625\u0633 \u0622\u0631 \u0645\u0635\u0631\",\"description\":\"The first portal for CSR in Egypt and Middle East\",\"publisher\":{\"@id\":\"https:\/\/csregypt.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/csregypt.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/csregypt.com\/#organization\",\"name\":\"CSR\",\"url\":\"https:\/\/csregypt.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/csregypt.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.csregypt.com\/wp-content\/uploads\/2019\/05\/logos-7.png\",\"contentUrl\":\"https:\/\/www.csregypt.com\/wp-content\/uploads\/2019\/05\/logos-7.png\",\"width\":1080,\"height\":1080,\"caption\":\"CSR\"},\"image\":{\"@id\":\"https:\/\/csregypt.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/csregypt\/\",\"https:\/\/x.com\/egyptcsrforum\",\"https:\/\/www.instagram.com\/csr.egypt\/\",\"https:\/\/www.linkedin.com\/in\/csr-egypt-43381ab5\/\",\"https:\/\/www.pinterest.com.au\/csregypt\/\",\"https:\/\/www.youtube.com\/channel\/UCh21PZpnBj2yjj2PeclXz1g\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/csregypt.com\/#\/schema\/person\/5df2c73ec5c5eaada424a85f98cd7bec\",\"name\":\"Marwa Zein\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/csregypt.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/383ed3b7c60ec18a972e284b402d1b29?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/383ed3b7c60ec18a972e284b402d1b29?s=96&d=mm&r=g\",\"caption\":\"Marwa Zein\"},\"sameAs\":[\"http:\/\/marwazein1982@gmail.com\"],\"url\":\"https:\/\/csregypt.com\/en\/author\/marwa-zein\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"EIB provides \u20ac22\u00a0m to Poland\u2019s Ryvu Therapeutics to develop new cancer treatment - Csr Egypt","description":"EIB is providing \u20ac22\u00a0million \u00a0in financing\u00a0to Ryvu Therapeutics, a Polish\u00a0clinical-stage drug discovery and development company, to develop new cancer treatment.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/csregypt.com\/en\/eib-provides-e22-m-to-polands-ryvu-therapeutics-to-develop-new-cancer-treatment\/","og_locale":"en_US","og_type":"article","og_title":"EIB provides \u20ac22\u00a0m to Poland\u2019s Ryvu Therapeutics to develop new cancer treatment - Csr Egypt","og_description":"EIB is providing \u20ac22\u00a0million \u00a0in financing\u00a0to Ryvu Therapeutics, a Polish\u00a0clinical-stage drug discovery and development company, to develop new cancer treatment.","og_url":"https:\/\/csregypt.com\/en\/eib-provides-e22-m-to-polands-ryvu-therapeutics-to-develop-new-cancer-treatment\/","og_site_name":"Csr Egypt","article_publisher":"https:\/\/www.facebook.com\/csregypt\/","article_published_time":"2022-08-18T22:29:24+00:00","og_image":[{"width":600,"height":544,"url":"https:\/\/csregypt.com\/wp-content\/uploads\/2022\/08\/Untitled-17.png","type":"image\/png"}],"author":"Marwa Zein","twitter_card":"summary_large_image","twitter_creator":"@egyptcsrforum","twitter_site":"@egyptcsrforum","twitter_misc":{"Written by":"Marwa Zein","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/csregypt.com\/en\/eib-provides-e22-m-to-polands-ryvu-therapeutics-to-develop-new-cancer-treatment\/#article","isPartOf":{"@id":"https:\/\/csregypt.com\/en\/eib-provides-e22-m-to-polands-ryvu-therapeutics-to-develop-new-cancer-treatment\/"},"author":{"name":"Marwa Zein","@id":"https:\/\/csregypt.com\/#\/schema\/person\/5df2c73ec5c5eaada424a85f98cd7bec"},"headline":"EIB provides \u20ac22\u00a0m to Poland\u2019s Ryvu Therapeutics to develop new cancer treatment","datePublished":"2022-08-18T22:29:24+00:00","dateModified":"2022-08-18T22:29:24+00:00","mainEntityOfPage":{"@id":"https:\/\/csregypt.com\/en\/eib-provides-e22-m-to-polands-ryvu-therapeutics-to-develop-new-cancer-treatment\/"},"wordCount":458,"commentCount":0,"publisher":{"@id":"https:\/\/csregypt.com\/#organization"},"image":{"@id":"https:\/\/csregypt.com\/en\/eib-provides-e22-m-to-polands-ryvu-therapeutics-to-develop-new-cancer-treatment\/#primaryimage"},"thumbnailUrl":"https:\/\/csregypt.com\/wp-content\/uploads\/2022\/08\/Untitled-17.png","articleSection":["health","news"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/csregypt.com\/en\/eib-provides-e22-m-to-polands-ryvu-therapeutics-to-develop-new-cancer-treatment\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/csregypt.com\/en\/eib-provides-e22-m-to-polands-ryvu-therapeutics-to-develop-new-cancer-treatment\/","url":"https:\/\/csregypt.com\/en\/eib-provides-e22-m-to-polands-ryvu-therapeutics-to-develop-new-cancer-treatment\/","name":"EIB provides \u20ac22\u00a0m to Poland\u2019s Ryvu Therapeutics to develop new cancer treatment - Csr Egypt","isPartOf":{"@id":"https:\/\/csregypt.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/csregypt.com\/en\/eib-provides-e22-m-to-polands-ryvu-therapeutics-to-develop-new-cancer-treatment\/#primaryimage"},"image":{"@id":"https:\/\/csregypt.com\/en\/eib-provides-e22-m-to-polands-ryvu-therapeutics-to-develop-new-cancer-treatment\/#primaryimage"},"thumbnailUrl":"https:\/\/csregypt.com\/wp-content\/uploads\/2022\/08\/Untitled-17.png","datePublished":"2022-08-18T22:29:24+00:00","dateModified":"2022-08-18T22:29:24+00:00","description":"EIB is providing \u20ac22\u00a0million \u00a0in financing\u00a0to Ryvu Therapeutics, a Polish\u00a0clinical-stage drug discovery and development company, to develop new cancer treatment.","breadcrumb":{"@id":"https:\/\/csregypt.com\/en\/eib-provides-e22-m-to-polands-ryvu-therapeutics-to-develop-new-cancer-treatment\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/csregypt.com\/en\/eib-provides-e22-m-to-polands-ryvu-therapeutics-to-develop-new-cancer-treatment\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/csregypt.com\/en\/eib-provides-e22-m-to-polands-ryvu-therapeutics-to-develop-new-cancer-treatment\/#primaryimage","url":"https:\/\/csregypt.com\/wp-content\/uploads\/2022\/08\/Untitled-17.png","contentUrl":"https:\/\/csregypt.com\/wp-content\/uploads\/2022\/08\/Untitled-17.png","width":600,"height":544,"caption":"EIB provides \u20ac22\u00a0m to Poland\u2019s Ryvu Therapeutics to develop new cancer treatment"},{"@type":"BreadcrumbList","@id":"https:\/\/csregypt.com\/en\/eib-provides-e22-m-to-polands-ryvu-therapeutics-to-develop-new-cancer-treatment\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/csregypt.com\/"},{"@type":"ListItem","position":2,"name":"EIB provides \u20ac22\u00a0m to Poland\u2019s Ryvu Therapeutics to develop new cancer treatment"}]},{"@type":"WebSite","@id":"https:\/\/csregypt.com\/#website","url":"https:\/\/csregypt.com\/","name":"\u0633\u064a \u0625\u0633 \u0622\u0631 \u0645\u0635\u0631","description":"The first portal for CSR in Egypt and Middle East","publisher":{"@id":"https:\/\/csregypt.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/csregypt.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/csregypt.com\/#organization","name":"CSR","url":"https:\/\/csregypt.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/csregypt.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.csregypt.com\/wp-content\/uploads\/2019\/05\/logos-7.png","contentUrl":"https:\/\/www.csregypt.com\/wp-content\/uploads\/2019\/05\/logos-7.png","width":1080,"height":1080,"caption":"CSR"},"image":{"@id":"https:\/\/csregypt.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/csregypt\/","https:\/\/x.com\/egyptcsrforum","https:\/\/www.instagram.com\/csr.egypt\/","https:\/\/www.linkedin.com\/in\/csr-egypt-43381ab5\/","https:\/\/www.pinterest.com.au\/csregypt\/","https:\/\/www.youtube.com\/channel\/UCh21PZpnBj2yjj2PeclXz1g"]},{"@type":"Person","@id":"https:\/\/csregypt.com\/#\/schema\/person\/5df2c73ec5c5eaada424a85f98cd7bec","name":"Marwa Zein","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/csregypt.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/383ed3b7c60ec18a972e284b402d1b29?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/383ed3b7c60ec18a972e284b402d1b29?s=96&d=mm&r=g","caption":"Marwa Zein"},"sameAs":["http:\/\/marwazein1982@gmail.com"],"url":"https:\/\/csregypt.com\/en\/author\/marwa-zein\/"}]}},"jetpack_featured_media_url":"https:\/\/csregypt.com\/wp-content\/uploads\/2022\/08\/Untitled-17.png","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/csregypt.com\/en\/wp-json\/wp\/v2\/posts\/79686"}],"collection":[{"href":"https:\/\/csregypt.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/csregypt.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/csregypt.com\/en\/wp-json\/wp\/v2\/users\/410"}],"replies":[{"embeddable":true,"href":"https:\/\/csregypt.com\/en\/wp-json\/wp\/v2\/comments?post=79686"}],"version-history":[{"count":1,"href":"https:\/\/csregypt.com\/en\/wp-json\/wp\/v2\/posts\/79686\/revisions"}],"predecessor-version":[{"id":79689,"href":"https:\/\/csregypt.com\/en\/wp-json\/wp\/v2\/posts\/79686\/revisions\/79689"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/csregypt.com\/en\/wp-json\/wp\/v2\/media\/79687"}],"wp:attachment":[{"href":"https:\/\/csregypt.com\/en\/wp-json\/wp\/v2\/media?parent=79686"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/csregypt.com\/en\/wp-json\/wp\/v2\/categories?post=79686"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/csregypt.com\/en\/wp-json\/wp\/v2\/tags?post=79686"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}